BeStock  

Lantheus LNTH

US equityMarket cap rank #1764Drug Manufacturers - Specialty & Generic
$102.10 +$0.00 (0.00%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $102.10 0.00%
Open$102.10
Prev close$102.10
Day range$102.07 – $102.40
Volume1.07M
Market cap$6.68B
P/E (TTM)25.4
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$389.91M+1.5% YoY
Operating profit$32.21M-26.2% YoY
Net profit$22.37M-19.4% YoY
Diluted EPS$0.33-19.5% YoY
Free cash flow$94.28M-0.4% YoY
Operating cash flow$101.97M

Revenue, last 8 quarters

$391.1MDec '24$372.8MMar '25$378.0MJun '25$384.0MSep '25$406.8MDec '25$377.3MMar '26$388.2MJun '26$389.9MSep '26

Net profit, last 8 quarters

$-11.8MDec '24$72.9MMar '25$78.8MJun '25$27.8MSep '25$54.1MDec '25$118.4MMar '26$75.0MJun '26$22.4MSep '26

Diluted EPS by quarter

-0.17Dec '241.02Mar '251.12Jun '250.41Sep '250.82Dec '251.80Mar '261.11Jun '260.33Sep '26

Free cash flow by quarter

$113.4MDec '24$98.8MMar '25$73.7MJun '25$94.7MSep '25$81.4MDec '25$121.9MMar '26$89.9MJun '26$94.3MSep '26

Annual revenue

$339.4MFY20$425.2MFY21$935.1MFY22$1.3BFY23$1.5BFY24$1.5BFY25

Profitability & balance sheet

Gross margin61.3%
Operating margin18.6%
Net margin17.3%
Return on equity21.8%
Return on assets11.4%
Return on invested capital14.5%
Current ratio3.25
Liabilities / assets44.8%
Cash & investments$683.61M
Total debt$624.28M
Net cash (debt)$59.33M
Free cash flow / sales24.8%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • PYLARIFY$238.93M 61.3%
  • DEFINITY$85.67M 22.0%
  • Neuraceq$45.58M 11.7%
  • Strategic partnerships and other$19.73M 5.1%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $389.91M $388.18M $377.33M $1.54B $406.79M
Total Operating Revenue $389.91M $388.18M $377.33M $1.54B $406.79M
Cost of Revenue $146.50M $146.33M $146.41M $599.66M $165.91M
Gross Profit $243.41M $241.86M $230.92M $941.95M $240.88M
Operating Expense $211.21M $141.64M $149.60M $626.39M $163.69M
Selling and Admin Expenses $118.44M $103.44M $110.22M $453.81M $116.21M
-Selling & Marketing Expense $48.06M $82.81M $52.68M $178.69M $46.32M
-General & Admin Expense $70.38M $20.63M $57.53M $275.12M $69.89M
Research & Development $92.76M $38.20M $39.38M $177.31M $47.48M
Operating Profit $32.21M $100.22M $81.33M $315.56M $77.18M
Net Non-Operating Interest Income (Expense) $2.01M $1.34M $105,000.00 $3.64M -$2.01M
Non-Operating Interest Income $6.95M $6.26M $4.97M $23.39M $3.07M
Non-Operating Interest Expense $4.94M $4.92M $4.86M $19.75M $5.08M
Other Income (Expense) -$12.44M -$7.73M $74.97M -$5.41M -$4.81M
Gain on Sale of Security -$11.98M -$10.45M $16.11M -$9.62M -$9.81M
Special Income (Charges) -$83,000.00 $199,000.00 $59.33M $4.27M $4.27M
-Gain on Sale Of Business -$83,000.00 $199,000.00 $59.33M – –
Other Non-Operating Income (Expenses) -$377,000.00 $2.51M -$462,000.00 -$52,000.00 $725,000.00
Pretax Profit $21.78M $93.83M $156.41M $313.79M $70.37M
Tax -$594,000.00 $18.80M $37.99M $80.23M $16.28M
Net Profit $22.37M $75.03M $118.42M $233.56M $54.09M
Profit from Continuing Operations $22.37M $75.03M $118.42M $233.56M $54.09M
Net Income to Parent Company $22.37M $75.03M $118.42M $233.56M $54.09M
Net Income to Common Stockholders $22.37M $75.03M $118.42M $233.56M $54.09M
Basic EPS $0.34 $1.15 $1.83 $3.46 $0.82
Diluted EPS $0.33 $1.11 $1.80 $3.41 $0.82
Other Operating Expenses – – – -$4.73M $0.00
-Less:Other Special Charges – – – $734,000.00 –
-Gain on Sale of Property/Plant/Equipment – – – $5.00M $5.00M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.46B $2.41B $2.35B $2.23B $2.23B
Total Current Assets $1.12B $1.03B $942.29M $899.96M $899.96M
Cash and Cash Equivalents & Short-Term Investments $683.61M $593.30M $498.58M $359.12M $359.12M
-Cash and Cash Equivalents $683.61M $593.30M $498.58M $359.12M $359.12M
Receivables $345.68M $354.06M $357.15M $374.03M $374.03M
-Accounts Receivable $345.68M $352.89M $355.67M $358.64M $358.64M
-Taxes Receivable $0.00 $1.17M $1.49M $15.39M $15.39M
Inventory $64.21M $57.55M $61.34M $64.67M $64.67M
Other Current Assets $30.20M $22.15M $25.21M $650,000.00 $650,000.00
Total Non-Current Assets $1.33B $1.39B $1.40B $1.33B $1.33B
Net PPE $149.63M $153.27M $157.56M $194.66M $194.66M
-Gross PPE $228.68M $237.19M $239.27M $267.45M $267.45M
-Accumulated Depreciation -$79.05M -$83.92M -$81.71M -$72.79M -$72.79M
Investments and Advances $98.43M $118.98M $58.31M $42.21M $42.21M
-Available for Sale Securities $98.43M $118.98M $58.31M $42.21M $42.21M
Non-Current Note Receivables $25.30M $24.53M $92.10M – –
Goodwill and Other Intangible Assets $880.24M $928.39M $945.46M $962.30M $962.30M
-Goodwill $238.63M $239.05M $239.40M $239.52M $239.52M
-Other Intangible Assets $641.61M $689.34M $706.06M $722.78M $722.78M
Non-Current Deferred Assets $121.14M $102.72M $89.12M $109.20M $109.20M
Other Non-Current Assets $57.70M $59.72M $61.74M $19.07M $19.07M
Total Liabilities $1.10B $1.10B $1.13B $1.14B $1.14B
Total Current Liabilities $345.97M $335.68M $333.17M $333.42M $333.42M
Payables $51.04M $52.14M $68.02M $46.48M $46.48M
-Accounts Payable $47.70M $48.11M $45.88M $42.91M $42.91M
-Total Tax Payable $3.34M $4.03M $22.15M $3.57M $3.57M
Current Accrued Expenses $209.03M $208.47M $180.76M $181.92M $181.92M
Short-Term Debt and Capital Lease Obligation $605,000.00 $697,000.00 $803,000.00 $738,000.00 $738,000.00
-Current Debt $605,000.00 $697,000.00 $803,000.00 $738,000.00 $738,000.00
Other Current Liabilities $35.12M $28.62M $35.07M $41.04M $41.04M
Total Non-Current Liabilities $754.45M $767.21M $801.13M $804.18M $804.18M
Long Term Debt and Capital Lease Obligation $623.68M $624.26M $624.95M $618.69M $618.69M
-Long Term Debt $571.14M $570.35M $569.60M $568.68M $568.68M
-Long Term Capital Lease Obligation $52.54M $53.91M $55.35M $50.02M $50.02M
Non-Current Liabilities $257,000.00 $140,000.00 $139,000.00 $138,000.00 $138,000.00
Non-Current Deferred Liabilities $41.14M $54.06M $53.51M $54.25M $54.25M
Other Non-Current Liabilities $89.38M $88.75M $122.54M $131.11M $131.11M
Total Equity $1.36B $1.31B $1.21B $1.09B $1.09B
Stockholders' Equity $1.36B $1.31B $1.21B $1.09B $1.09B
Capital Stock $726,000.00 $725,000.00 $723,000.00 $718,000.00 $718,000.00
-Common Stock $726,000.00 $725,000.00 $723,000.00 $718,000.00 $718,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $939.32M $917.71M $892.95M $888.32M $888.32M
Retained Earnings $895.32M $872.95M $797.92M $679.50M $679.50M
Less: Treasury Stock -$477.44M -$477.44M -$477.44M -$477.44M -$477.44M
Gains/Losses Not Affecting Retained Earnings -$2.22M -$2.17M -$1.87M -$1.31M -$1.31M
Prepaid Assets – – – $20.75M $20.75M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $101.97M $92.20M $125.13M $390.14M $90.18M
Net cash flow from continuing operations $101.97M $92.20M $125.13M $390.14M $90.18M
Net Income from Continuing Operations $22.37M $75.03M $118.42M $233.56M $54.09M
Gain/Loss from Continuing Operations -$2.44M -$199,000.00 -$59.33M -$5.00M –
Depreciation & Depletion & Amortization $22.90M $22.58M $22.68M $70.10M $22.83M
Deferred Tax -$42.73M -$12.47M $19.41M $21.84M $1.22M
Other Non-Cash Items $44.21M -$33.80M -$1.56M $22.22M $6.96M
Change in Working Capital -$8.94M $11.07M $22.83M -$44.23M -$16.29M
-Change in Receivables $6.91M $3.28M -$2.23M -$17.89M -$2.07M
-Change in Inventory -$8.24M $3.30M $2.11M -$9.37M -$3.04M
-Change in Payables and Accrued Expense $1.87M -$599,000.00 $23.19M -$11.57M -$12.12M
-Change in Other Current Assets -$9.49M $5.09M -$244,000.00 -$5.41M $938,000.00
Net cash flow from investing -$11.14M -$2.02M $25.99M -$627.17M -$11.51M
Net Cash Flow from Continuing Investing Activities -$11.14M -$2.02M $25.99M -$627.17M -$11.51M
Capital Expenditure -$2.05M -$2.34M -$3.23M -$36.09M -$8.79M
Net Intangibles Purchase and Sale -$5.65M – – -$5.41M $0.00
Net Business Purchase and Sale $688,000.00 $312,000.00 $24.21M -$585.67M -$311.73M
Net Other Investing Changes -$12.69M $0.00 $5.00M – –
Financing Cash Flow -$460,000.00 $4.51M -$11.62M -$316.58M -$100.79M
Net Cash Flow from Continuing Financing Activities -$460,000.00 $4.51M -$11.62M -$316.58M -$100.79M
Net Issuance Payments Of Debt -$200,000.00 -$248,000.00 -$216,000.00 -$1.11M -$353,000.00
Net Common Stock Issuance $0.00 $0.00 $0.00 -$296.29M -$96.29M
Proceeds from Stock Option Exercised $3.16M $6.86M $4.29M $7.15M -$3.05M
Net Other Financing Charges -$3.42M -$2.10M -$15.70M -$26.34M -$1.10M
Ending Cash Balance $685.33M $595.02M $500.29M $360.83M $360.83M
Net Change in Cash $90.38M $94.69M $139.49M -$553.61M -$22.12M
Beginning Cash Balance $595.02M $500.29M $360.83M $914.49M $383.70M
Effect of Exchange Rate Changes -$61,000.00 $36,000.00 -$22,000.00 -$49,000.00 -$760,000.00
Free Cash Flow $94.28M $89.87M $121.90M $348.64M $81.39M

Discussion

No comments yet — be the first to weigh in on LNTH.

Sign in to join the discussion.

Scroll to Top